| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |